February 16, 2018 / 7:37 PM / in 6 months

BRIEF-Great Point Partners Opposes Biocryst Pharma Proposed Merger With Idera Pharma

Feb 16 (Reuters) - Great Point Partners LLC:

* GREAT POINT PARTNERS LLC OPPOSES THE BIOCRYST PHARMACEUTICAL PROPOSED MERGER WITH IDERA PHARMACEUTICALS, INC.

* ‍GREAT POINT PARTNERS, LLC SAYS BENEFICIALLY OWNING ABOUT 7.5 MILLION SHARES OF COMMON STOCK OF BIOCRYST PHARMACEUTICALS​

* GREAT POINT PARTNERS SAYS BELIEVE BIOCRYST PHARMA’S SHARES ARE “UNDERVALUED”

* GREAT POINT PARTNERS SAYS BELIEVE IT IS “INCUMBENT” UPON BIOCRYST PHARMACEUTICAL BOARD TO EXPLORE ALTERNATIVE STRATEGIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below